Aminopeptidase B (AP-B) is a crucial enzyme involved in protein metabolism, specifically responsible for cleaving arginine or lysine residues from the N-terminus of peptides. This enzymatic activity plays a significant role in various physiological processes, including the maturation and degradation of peptide hormones, neuropeptides, and cytokines, which are vital for maintaining homeostasis within the body. For example, by processing peptide precursors, AP-B can influence the bioactivity of these molecules, affecting processes such as inflammation, pain modulation, and blood pressure regulation. Additionally, AP-B is implicated in the antigen presentation pathway, where it helps in the generation of peptide fragments suitable for presentation by MHC class I molecules, thus participating in the immune response. The broad spectrum of AP-B's involvement highlights its importance in cellular and systemic functions, where it ensures the proper regulation and turnover of bioactive peptides.
The activation of Aminopeptidase B is tightly regulated by various biochemical and cellular mechanisms to ensure its activity is aligned with the body's metabolic and physiological needs. One primary method of AP-B activation involves its synthesis as an inactive zymogen, which requires proteolytic cleavage for activation. This mechanism ensures that AP-B is activated only in specific cellular contexts or in response to particular physiological stimuli, preventing unwanted breakdown of peptides. Additionally, the activity of AP-B can be modulated by factors such as pH and the presence of metal ions, with zinc being particularly crucial for its catalytic activity. Zinc ions bind to the active site of AP-B, facilitating the formation of a catalytically competent structure that can effectively bind and cleave substrates. Furthermore, the localization of AP-B within the cell, typically in the cytosol and sometimes associated with membrane structures, also influences its activation, as interaction with membrane-bound receptors or substrates can modulate its enzymatic efficiency. Such regulation of activity and function allows AP-B to meet the dynamic needs of the cell and organism, adapting to changes in the internal and external environment to maintain cellular function and contribute to physiological processes effectively. Understanding these mechanisms of activation and regulation provides insight into the complex interplay of factors that govern peptide metabolism and the role of AP-B in health and disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Inhibits various proteases. By inhibiting these proteases, RNPEP's activity can be indirectly enhanced to compensate degradation. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
A cysteine protease inhibitor. By blocking these proteases, it can indirectly affect RNPEP's role in peptide processing. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that affects protein degradation, potentially leading to enhanced RNPEP activity. | ||||||
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $131.00 | 19 | |
Inhibits aminopeptidases. While it might inhibit RNPEP, it can also modulate its overall activity in a complex manner. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
It affects protein metabolism and can, in turn, modulate the activity of enzymes like RNPEP involved in protein turnover. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cellular cAMP levels, which can modulate protein metabolism pathways, potentially affecting RNPEP. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, they modulate protein synthesis and degradation, which might impact RNPEP. | ||||||
Lys05 | 1391426-24-6 | sc-507532 | 5 mg | $140.00 | ||
A dimeric chloroquine which affects lysosomal function, potentially influencing RNPEP activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, affecting various cellular pathways, potentially including those involving RNPEP. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation which can lead to protein misfolding, affecting proteostasis and potentially RNPEP. | ||||||